October 9, 2017 by Chain Drug Review
Brian Tanquilut, Jeffries, Rite Aid, Scott Mushkin, Walgreens Boots Alliance, Walgreens-Rite Aid merger, Wolfe Research
2017, Issue 10-09-2017, Issues, News
NEW YORK — Wall Street analysts say the fog around Walgreens Boots Alliance Inc. and Rite Aid Corp. is set to clear after a nearly two-year process that culminated in an unsuccessful merger and a deal to sell over 40% of Rite Aid’s stores to WBA. The Federal Trade Commission late last month approved a
September 20, 2017 by Chain Drug Review
Brian Tanquilut, Rite Aid, Scott Mushkin, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger, Wolfe Research, Zacks Investment Research
Business, Featured Articles, Leading Headlines, Retail News

NEW YORK — The impending closure of Walgreens Boots Alliance’s purchase of nearly 2,000 Rite Aid stores will clear the fog around both companies since their terminated merger deal and enable them to move ahead, Wall Street analysts say. WBA and Rite Aid yesterday announced that the Federal Trade Commission approved a downsized agreement in
April 26, 2017 by CDR Blog and Chain Drug Review
Albertsons, Amazon, Cerberus Capital Management, JANA Partners, Scott Mushkin, Sprouts Farmers Markets, Walgreens-Rite Aid merger, Whole Foods Markets, Wolfe Research
CDR Blog

Albertsons Cos. reportedly is eyeing Whole Foods Markets, but it appears such an acquisition would be difficult for the Boise-based food and drug retailer to swallow. The Financial Times reported this week that Cerberus Capital Management, which leads the investor group that owns Albertsons, has engaged in preliminary discussions with bankers about a possible bid
April 4, 2017 by Chain Drug Review
Fred's, Jim Cramer, Scott Mushkin, video, Walgreens Boots Alliance, Walgreens-Rite Aid, Walgreens-Rite Aid merger, Wolfe Research
Videos

Like everyone else waiting for the wrap-up of the Walgreens-Rite Aid merger, investment pundit Jim Cramer of TheStreet.com and CNBC’s “Mad Money” is getting impatient over the plodding antitrust review negotiations. Now approaching its 18th month, Walgreens Boots Alliance’s planned acquisition of Rite Aid has a deal end date of July 31, as per an
September 29, 2016 by CDR Blog and Chain Drug Review
chain drug industry, CVS, Federal Trade Commission, Kroger, Rite Aid, Scott Mushkin, Walgreens Boots Alliance, Walmart, WBA, Wolfe Research
CDR Blog

It looks like one divestment possibility for Walgreens Boots Alliance isn’t panning out as it works with the Federal Trade Commission to gain antitrust clearance for its acquisition of Rite Aid. The New York Post reported this week that WBA hasn’t been able to sway private equity firms to buy a chunk of Walgreens and/or
July 15, 2016 by CDR Blog
Federal Trade Commission, FTC, Rite Aid, Scott Mushkin, Stefano Pessina, Walgreens Boots Alliance, Wolfe Research
CDR Blog, Leading Headlines

It looks like Walgreens Boots Alliance is getting down to brass tacks in its negotiations with the Federal Trade Commission to acquire Rite Aid. The New York Post reported late Thursday evening that WBA is discussing store divestitures with the FTC and trying to get a bead on the number of Walgreens and/or Rite Aid
April 25, 2016 by CDR Blog
Curbside, CVS Health, CVS Pharmacy, Scott Mushkin, Wolfe Research
CDR Blog

CVS Health’s partnership with and investment in Curbside could help CVS Pharmacy enhance its front-end business by picking up some purchases that may be migrating to online retailers, according to analyst Scott Mushkin of Wolfe Research. ‘Where Do You Buy Your Everyday Essentials?’ Source: Wolfe Research, “Pure Food Trend Matures” (4/1/16). CVS announced last week